Lung cancer patients in England to receive Amgen drug that targets a gene mutation

FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith (UNITED STATES/File PhotoLONDON (Reuters) – Lung cancer patients in England will become the first in Europe to receive a drug made by U.S. biotech Amgen Inc that targets a specific gene mutation, the country’s… Continue reading Lung cancer patients in England to receive Amgen drug that targets a gene mutation